METHOD OF DIAGNOSING AND TREATING CHRONIC KIDNEY DISEASE

METHOD OF DIAGNOSING AND TREATING CHRONIC KIDNEY DISEASE

A method of diagnosing and/or treating stage 3 or stage 4 chronic kidney disease (CKD) is provided herein, where a proUGN concentration level of 2.241 ng/ml or higher is indicative of stage 3 or stage 4 CKD. Additionally, a method of diagnosing and/or treating pre-CKD is also provided herein, where...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: KEMPER, Nicholas, CARRITHERS, Brennan M, MORRISON, Luke E, CARRITHERS, Stephen L, CARRITHERS, Aaron L
Format: Patent
Sprache:eng
Schlagworte:
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
PHYSICS
TESTING
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator KEMPER, Nicholas
CARRITHERS, Brennan M
MORRISON, Luke E
CARRITHERS, Stephen L
CARRITHERS, Aaron L
description A method of diagnosing and/or treating stage 3 or stage 4 chronic kidney disease (CKD) is provided herein, where a proUGN concentration level of 2.241 ng/ml or higher is indicative of stage 3 or stage 4 CKD. Additionally, a method of diagnosing and/or treating pre-CKD is also provided herein, where a proUGN concentration level of 2.05 ng/ml to and including 2.24 ng/ml in a biological sample is indicative of pre-CKD and that a patient is at risk of developing CKD. The methods may comprise measuring the amount of proUGN in a biological sample of the patient and/or administering a CKD-therapeutic agent and/or providing lifestyle and/or dietary modifications to the patient.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2024345103A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2024345103A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2024345103A13</originalsourceid><addsrcrecordid>eNrjZLDwdQ3x8HdR8HdTcPF0dPfzD_b0c1dw9HNRCAlydQwBcZw9gvz9PJ0VvD1d_FwjgcqCXR2DXXkYWNMSc4pTeaE0N4Oym2uIs4duakF-fGpxQWJyal5qSXxosJGBkYmxiamhgbGjoTFxqgDjqykV</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>METHOD OF DIAGNOSING AND TREATING CHRONIC KIDNEY DISEASE</title><source>esp@cenet</source><creator>KEMPER, Nicholas ; CARRITHERS, Brennan M ; MORRISON, Luke E ; CARRITHERS, Stephen L ; CARRITHERS, Aaron L</creator><creatorcontrib>KEMPER, Nicholas ; CARRITHERS, Brennan M ; MORRISON, Luke E ; CARRITHERS, Stephen L ; CARRITHERS, Aaron L</creatorcontrib><description>A method of diagnosing and/or treating stage 3 or stage 4 chronic kidney disease (CKD) is provided herein, where a proUGN concentration level of 2.241 ng/ml or higher is indicative of stage 3 or stage 4 CKD. Additionally, a method of diagnosing and/or treating pre-CKD is also provided herein, where a proUGN concentration level of 2.05 ng/ml to and including 2.24 ng/ml in a biological sample is indicative of pre-CKD and that a patient is at risk of developing CKD. The methods may comprise measuring the amount of proUGN in a biological sample of the patient and/or administering a CKD-therapeutic agent and/or providing lifestyle and/or dietary modifications to the patient.</description><language>eng</language><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES ; MEASURING ; PHYSICS ; TESTING</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20241017&amp;DB=EPODOC&amp;CC=US&amp;NR=2024345103A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,778,883,25553,76306</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20241017&amp;DB=EPODOC&amp;CC=US&amp;NR=2024345103A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>KEMPER, Nicholas</creatorcontrib><creatorcontrib>CARRITHERS, Brennan M</creatorcontrib><creatorcontrib>MORRISON, Luke E</creatorcontrib><creatorcontrib>CARRITHERS, Stephen L</creatorcontrib><creatorcontrib>CARRITHERS, Aaron L</creatorcontrib><title>METHOD OF DIAGNOSING AND TREATING CHRONIC KIDNEY DISEASE</title><description>A method of diagnosing and/or treating stage 3 or stage 4 chronic kidney disease (CKD) is provided herein, where a proUGN concentration level of 2.241 ng/ml or higher is indicative of stage 3 or stage 4 CKD. Additionally, a method of diagnosing and/or treating pre-CKD is also provided herein, where a proUGN concentration level of 2.05 ng/ml to and including 2.24 ng/ml in a biological sample is indicative of pre-CKD and that a patient is at risk of developing CKD. The methods may comprise measuring the amount of proUGN in a biological sample of the patient and/or administering a CKD-therapeutic agent and/or providing lifestyle and/or dietary modifications to the patient.</description><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</subject><subject>MEASURING</subject><subject>PHYSICS</subject><subject>TESTING</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLDwdQ3x8HdR8HdTcPF0dPfzD_b0c1dw9HNRCAlydQwBcZw9gvz9PJ0VvD1d_FwjgcqCXR2DXXkYWNMSc4pTeaE0N4Oym2uIs4duakF-fGpxQWJyal5qSXxosJGBkYmxiamhgbGjoTFxqgDjqykV</recordid><startdate>20241017</startdate><enddate>20241017</enddate><creator>KEMPER, Nicholas</creator><creator>CARRITHERS, Brennan M</creator><creator>MORRISON, Luke E</creator><creator>CARRITHERS, Stephen L</creator><creator>CARRITHERS, Aaron L</creator><scope>EVB</scope></search><sort><creationdate>20241017</creationdate><title>METHOD OF DIAGNOSING AND TREATING CHRONIC KIDNEY DISEASE</title><author>KEMPER, Nicholas ; CARRITHERS, Brennan M ; MORRISON, Luke E ; CARRITHERS, Stephen L ; CARRITHERS, Aaron L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2024345103A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2024</creationdate><topic>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</topic><topic>MEASURING</topic><topic>PHYSICS</topic><topic>TESTING</topic><toplevel>online_resources</toplevel><creatorcontrib>KEMPER, Nicholas</creatorcontrib><creatorcontrib>CARRITHERS, Brennan M</creatorcontrib><creatorcontrib>MORRISON, Luke E</creatorcontrib><creatorcontrib>CARRITHERS, Stephen L</creatorcontrib><creatorcontrib>CARRITHERS, Aaron L</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>KEMPER, Nicholas</au><au>CARRITHERS, Brennan M</au><au>MORRISON, Luke E</au><au>CARRITHERS, Stephen L</au><au>CARRITHERS, Aaron L</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>METHOD OF DIAGNOSING AND TREATING CHRONIC KIDNEY DISEASE</title><date>2024-10-17</date><risdate>2024</risdate><abstract>A method of diagnosing and/or treating stage 3 or stage 4 chronic kidney disease (CKD) is provided herein, where a proUGN concentration level of 2.241 ng/ml or higher is indicative of stage 3 or stage 4 CKD. Additionally, a method of diagnosing and/or treating pre-CKD is also provided herein, where a proUGN concentration level of 2.05 ng/ml to and including 2.24 ng/ml in a biological sample is indicative of pre-CKD and that a patient is at risk of developing CKD. The methods may comprise measuring the amount of proUGN in a biological sample of the patient and/or administering a CKD-therapeutic agent and/or providing lifestyle and/or dietary modifications to the patient.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US2024345103A1
source esp@cenet
subjects INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
PHYSICS
TESTING
title METHOD OF DIAGNOSING AND TREATING CHRONIC KIDNEY DISEASE
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T09%3A30%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=KEMPER,%20Nicholas&rft.date=2024-10-17&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2024345103A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true